beat initi expens initi
support margin weak economi
ep beat weak economi slow growth
ajg result per share best forecast due larg better result
corpor segment brokerag risk manag earn slightli
better expect due better margin materi effect
overal ep howev organ brokerag growth neg impact
point relat chang revenu due covid made chang bad debt
impair amort intang item decreas estim earn-out near-
term expect current econom condit limit growth enact signific
expens reduct initi neutral effect margin still net-net
reduc estim
expect zero modestli neg organ growth brokerag segment
next sever quarter mid-singl digit expect exposur declin
due rise unemploy decreas payrol insur valu mile driven
similarli risk manag neg affect reduct new claim
retail hospit transport restaur area focu combat
pressur top line result pressur margin extent manag
implement expens save initi million per quarter still
reduc expect margin improv go forward ajg clean energi
oper experienc lower coal-gener electr consumpt due reduc
econom activ fall natur ga price net-net reduc
forecast reduc project
assum normal organ growth rate year
modest ebitdac margin improv brokerag segment
 lower
lower target reflect lower estim po
base cash ep estim multipl support better-
than-expect normal growth driven success on-going strategi
averag normal organ growth oper leverag allow return
on-going margin improv lead double-digit ep growth time
reiter buy rate
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
total benefit claim
arthur gallagh world fourth-largest
risk manag servic via network
subsidiari place p/c reinsur surplu
line manag employe benefit program
risk manag servic perform
manag loss control consult worker
believ one best-run middle-
market insur broker organ growth
respond better price econom
environ growth along good
expens disciplin allow continu
margin improv acquisit remain
attract avenu growth above-averag
dividend yield attract sustain
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
po base cash ep estim premium
compar compani see justifi given better-than-expect
normal growth opportun driven success on-going strategi
averag normal organ growth oper leverag allow on-going
margin improv lead normal double-digit ep growth time
downsid risk price object softer property-casualty price
built expect poor integr one sever acquisit lower
industry-wid claim frequenc hurt claim manag busi rise
unemploy could hurt claim manag busi expos
worker compens residu environment tax liabil relat
synthet coal invest chang health care regul impact benefit
broke busi chang dividend strategi compani
alison jacobowitz herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
